Advertisement

Predictors for the risk and severity of post-thrombotic syndrome in vascular Behçet's disease

Published:February 19, 2021DOI:https://doi.org/10.1016/j.jvsv.2021.02.007

      Abstract

      Objective

      Deep vein thrombosis (DVT) of the lower extremities is the most common form of vascular involvement in Behçet disease (BD), frequently leading to post-thrombotic syndrome (PTS) as a disabling complication. We have described the clinical characteristics and predictors of PTS presence among patients with BD and lower extremity DVT. We also used venous Doppler ultrasound (US) examinations in our assessment.

      Methods

      Patients with BD (n = 205; 166 men, 39 women; age 39 ± 9.5 years) and a history of DVT were investigated. The Villalta scale was used to assess the presence and severity of PTS. Doppler US examinations were performed within 1 week of the clinical evaluation. The total number of vessels with reflux, thrombi, recanalization, and collateral vessels were calculated.

      Results

      Of the 205 patients with BD, 62% had had PTS and 18% had had severe PTS. Patients with PTS had had greater reflux (P = .054) and thrombosis (P = .02) scores compared with patients without PTS. Treatment with anticoagulation (AC), immunosuppressive (IS) therapy, or AC combined with IS drugs did not affect the occurrence of PTS. However, patients treated with IS therapy, with or without AC drugs, had a decreased incidence of severe PTS compared with the AC-only group (P = .017). Patients treated with AC plus IS agents also had increased collateral scores compared with patients treated with only IS drugs. Interferon-α use seemed to provide better recanalization scores compared with azathioprine only (1.0 [range, 0-14] vs 2.5 [range, 0-10]; P = .010).

      Conclusions

      Patients with BD and DVT have a high risk of developing severe PTS. IS treatment decreases the development of severe PTS. AC therapy might influence the course of PTS by increasing the collateral scores, and the use of interferon-α also increased recanalization scores. Routine assessment with Doppler US examinations could be helpful in the prediction of severe PTS.

      Key words

      To read this article in full you will need to make a payment
      SVS Member Login
      Society Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jennette J.C.
        Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides.
        Clin Exp Nephrol. 2013; 17: 603-606
        • Alibaz-Oner F.
        • Karadeniz A.
        • Ylmaz S.
        • Balkarlı A.
        • Kimyon G.
        • Yazıcı A.
        • et al.
        Behçet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses.
        Medicine (Baltimore). 2015; 94: e494
        • Tascilar K.
        • Melikoglu M.
        • Ugurlu S.
        • Sut N.
        • Caglar E.
        • Yazici H.
        Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course.
        Rheumatology (Oxford). 2014; 53: 2018-2022
        • Kahn S.R.
        • Partsch H.
        • Vedantham S.
        • Prandoni P.
        • Kearon C.
        Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization.
        J Thromb Haemost. 2009; 7: 879-883
        • Kahn S.R.
        How I treat postthrombotic syndrome.
        Blood. 2009; 114: 4624-4631
        • Alibaz-Oner F.
        • Aldag B.
        • Aldag M.
        • Unal A.U.
        • Mutis A.
        • Toptas T.
        • et al.
        Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular Behçet's disease.
        J Vasc Surg Venous Lymphat Disord. 2016; 4: 301-306
        • Seyahi E.
        • Cakmak O.S.
        • Tutar B.
        • Arslan C.
        • Dikici A.S.
        • Sut N.
        • et al.
        Clinical and ultrasonographic evaluation of lower-extremity vein thrombosis in Behçet syndrome: an observational study.
        Medicine (Baltimore). 2015; 94: e1899
      1. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's disease.
        Lancet. 1990; 335: 1078-1080
        • Yilmaz S.
        • Simsek I.
        • Cinar M.
        • Erdem H.
        • Kose O.
        • Yazici Y.
        • et al.
        Patient-driven assessment of disease activity in Behçet’s syndrome: cross-cultural adaptation, reliability and validity of the Turkish version of the Behçet’s Syndrome Activity Score.
        Clin Exp Rheumatol. 2013; 31: 77-83
        • Hatemi G.
        • Christensen R.
        • Bang D.
        • Bodaghi B.
        • Celik A.F.
        • Fortune F.
        • et al.
        2018 Update of the EULAR recommendations for the management of Behçet's syndrome.
        Ann Rheum Dis. 2018; 77: 808-818
        • Lurie F.
        • Passman M.
        • Meisner M.
        • Dalsing M.
        • Masuda E.
        • Welch H.
        • et al.
        The 2020 update of the CEAP classification system and reporting standards.
        J Vasc Surg Venous Lymphat Disord. 2020; 8: 342-352
        • Vasquez M.A.
        • Rabe E.
        • McLafferty R.B.
        • Shortell C.K.
        • Marston W.A.
        • Gillespie D.
        • et al.
        Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group.
        J Vasc Surg. 2010; 52: 1387-1396
        • Rutherford R.B.
        • Padberg Jr., F.T.
        • Comerota A.J.
        • Kistner R.L.
        • Meissner M.H.
        • Moneta G.L.
        Venous severity scoring: an adjunct to venous outcome assessment.
        J Vasc Surg. 2000; 31: 1307-1312
        • Hamper U.M.
        • DeJong M.R.
        • Scoutt L.M.
        Ultrasound evaluation of the lower extremity veins.
        Radiol Clin North Am. 2007; 45: 525-547
        • Lubberts B.
        • Pereira N.R.P.
        • Kabrhel C.
        • Kuter D.J.
        • DiGiovanni C.W.
        What is the effect of venous thromboembolism and related complications on patient reported health-related quality of life? A meta-analysis.
        Thromb Haemost. 2016; 116: 417-431
        • Schulman S.
        • Lindmarker P.
        • Holmstro M.
        • Larfars G.
        • Carlston A.
        • Nıcol P.
        • et al.
        Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months.
        J Thromb Haemost. 2006; 4: 734-742
        • Ende-Verhaar Y.M.
        • Tick L.W.
        • Klok F.A.
        • Huisman M.V.
        • Rosendaal F.R.
        • le Cessie S.
        • et al.
        Post-thrombotic syndrome: short and long-term incidence and risk factors.
        Thromb Res. 2019; 177: 102-109
        • Ozguler Y.
        • Hatemi G.
        • Cetinkaya F.
        • Tascilar K.
        • Hamuryudan V.
        • Ugurlu S.
        • et al.
        Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome.
        Rheumatology (Oxford). 2020; 59: 799-806
        • Kahn S.R.
        • Shrier I.
        • Julian J.A.
        • Ducruet T.
        • Arsenault L.
        • Miron M.J.
        • et al.
        Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis.
        Ann Intern Med. 2008; 149: 698-707
        • Tick L.W.
        • Doggen C.J.
        • Rosendaal F.R.
        • Faber W.R.
        • Bousema M.T.
        • Mackaay A.J.
        • et al.
        Predictors of the post-thrombotic syndrome with non-invasive venous examinations in patients 6 weeks after a first episode of deep vein thrombosis.
        J Thromb Haemost. 2010; 8: 2685-2692
        • Tick L.W.
        • Kramer M.H.
        • Rosendaal F.R.
        • Faber W.R.
        • Doggen C.J.
        Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis.
        J Thromb Haemost. 2008; 6: 2075-2081
        • Johnson B.F.
        • Manzo R.A.
        • Bergelin R.O.
        • Strandness D.E.
        Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up.
        J Vasc Surg. 1995; 21: 307-313
        • Prandoni P.
        • Villalta S.
        • Bagatella P.
        • Rossi L.
        • Marchiori A.
        • Piccioli A.
        • et al.
        The clinical course of deep-vein thrombosis. prospective long-term follow up 528 symptomatic patients.
        Haematologica. 1997; 82: 423-428
        • Galanaud J.P.
        • Holcroft C.A.
        • Rodger M.A.
        • Kovacs M.J.
        • Betancourt M.T.
        • Wells P.S.
        • et al.
        Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency.
        J Thromb Haemost. 2013; 11: 474-480
        • Galanaud J.P.
        • Bertoletti L.
        • Amitrano M.
        • Fernandez-Capitan C.
        • Pedrajas J.M.
        • Rosa V.
        • et al.
        Predictors of post-thrombotic ulcer after acute DVT: the RIETE registry.
        Thromb Haemost. 2018; 118: 320-328
        • Dronkers C.E.A.
        • Mol G.C.
        • Maraziti G.
        • van de Ree M.A.
        • Huisman M.V.
        • Becattini C.
        • et al.
        Predicting post-thrombotic syndrome with ultrasonographic follow-up after deep vein thrombosis: a systematic review and meta-analysis.
        Thromb Haemost. 2018; 118: 1428-1438
        • Latella J.
        • Desmarais S.
        • Miron M.J.
        • Roussin A.
        • Joyal F.
        • Kassis J.
        • et al.
        Relation between D-dimer level, venous valvular reflux and the development of post-thrombotic syndrome after deep vein thrombosis.
        J Thromb Haemost. 2010; 8: 2169-2175
        • Piovella F.
        • Crippa L.
        • Barone M.
        • D'Angelo S.V.
        • Serafani S.
        • Galli L.
        • et al.
        Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with DVT recurrence and new thrombosis.
        Haematologica. 2002; 87: 515-522
        • Labropoulos N.
        • Summers K.L.
        • Sanchez I.E.
        • Raffetto J.
        Saphenous vein wall thickness in age and venous reflux-associated remodeling in adults.
        J Vasc Surg Venous Lymphat Disord. 2017; 5: 216-223
        • Chandrashekar A.
        • Garry J.
        • Gasparis A.
        • Labropoulos N.
        Vein wall remodeling in patients with acute deep vein thrombosis and chronic postthrombotic changes.
        J Thromb Haemost. 2017; 15: 1989-1993
        • Matsumoto T.
        • Uekusa T.
        • Fukuda Y.
        Vasculo-Behçet’s disease: a pathologic study of eight cases.
        Hum Pathol. 1991; 22: 45-51
        • Seyahi E.
        • Gjoni M.
        • Durmaz E.S.
        • Akbas S.
        • Sut N.
        • Dikici A.S.
        • et al.
        Increased vein wall thickness in Behçet disease.
        J Vasc Surg Venous Lymphat Disord. 2019; 7 (677-84.e2)
        • Alibaz-Oner F.
        • Ergelen R.
        • Mutis A.
        • Erturk Z.
        • Asadov R.
        • Mumcu G.
        • et al.
        Venous vessel wall thickness in lower extremity is increased in male patients with Behçet's disease.
        Clin Rheumatol. 2019; 38: 1447-1451
        • Kisacik B.
        • Oren C.
        • Kasifoglu T.
        • Yilmaz S.
        • Yilmaz O.
        • Simsek I.
        • et al.
        Investigation of the veins in patients with Behçet's disease with no known vascular event by Doppler ultrasonography.
        Rheumatol Int. 2012; 32: 303-306
        • Alibaz-Oner F.
        • Karatay E.
        • Akpinar I.N.
        • Ergun T.
        • Direskeneli H.
        Evaluation of asymptomatic venous disease by venous Doppler ultrasonography in patients with Behçet's disease without overt thrombosis.
        Clin Rheumatol. 2014; 33: 277-280
        • Lee J.J.
        • Al-Jubouri M.
        • Acino R.
        • Comerota A.J.
        • Lurie F.
        Role of coexisting contralateral primary venous disease in development of post-thrombotic syndrome following catheter-based treatment of iliofemoral deep venous thrombosis.
        J Vasc Surg Venous Lymphat Disord. 2015; 3: 354-357
        • Chitsike R.S.
        • Rodger M.A.
        • Kovasc M.J.
        • Betancourt M.T.
        • Wells P.S.
        • Anderson D.R.
        • et al.
        Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study.
        J Thromb Haemost. 2012; 10: 2039-2044
        • Van Dongen CJJ
        • Prandoni P.
        • Frulla M.
        • Marchiori A.
        • Prins M.H.
        • Hutten B.A.
        Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome.
        J Thromb Haemost. 2005; 3: 939-942
        • Rabinovich A.
        • Cohen J.M.
        • Cushman M.
        • Wells P.S.
        • Rodger M.A.
        • Kovacs M.J.
        • et al.
        Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome.
        J Thromb Haemost. 2015; 13: 398-408
        • Downing J.L.
        • Strieter R.
        • Kadell A.M.
        • Wilke C.A.
        • Greenfield L.J.
        • Wakefield T.W.
        Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis.
        J Vasc Surg. 1998; 28: 848-854
        • San Norberto E.M.
        • Gastambide M.V.
        • Taylor J.H.
        • Garcia-Saiz I.
        • Vaquero C.
        Effects of rosuvastatin as an adjuvant treatment for deep vein thrombosis.
        Vasa. 2016; 45: 133-140